88 results

shutterstock_2029745357
Cardio

Posted on 04.11.2021

Heart failure – the time to act is now

With Europe’s ageing population comes several social, economic and environmental benefits. It also brings rising risks of cardiovascular disease (CVD) which must be managed to protect citizens’ wellbeing and the sustainability of our health systems. That is why we are inspired to see 15 European and international health organisations joining forces to form the European […]

By Markus Schwertfeger Senior Global Medical Affairs Lead Roche Diagnostics International

shutterstock_452431111
Cardio

Posted on 13.10.2021

How innovation is transforming stroke care?

Many of us know someone affected by stroke. It is the second leading cause of death globally and results in 50% of survivors being chronically disabled.[1] In Europe, the incident of stroke will have increased by 34% by the middle of the next decade. [2] The impact of stroke The impact on individuals and families […]

By Alenka Brzulja Vice President of Cardiovascular & Specialty Solutions EMEA, Johnson & Johnson Medical Devices Companies

shutterstock_1724121793
Ethics

Posted on 01.07.2021

Ethical collaborations: new guidelines help companies partner with patient organisations

One of the strongest trends I have observed in healthcare over the past decade has been the growth of patient power. Patients are actively shaping their care like never before. In response, health systems and companies are increasingly focused on the outcomes and experiences that matter to patients. The voice of patients is also becoming […]

By Clarisse Aillet Medical Education Consultant

CVD-MTE-Slider
Cardio

Posted on 27.05.2021

The need for an EU Action Plan for better cardiovascular health

Did you know that every day, some 5,000 people die from cardiovascular diseases (CVDs), amounting to 1.8 million deaths every year? This, unfortunately, makes cardiovascular disease – including heart failure, stroke-related atrial fibrillation, heart valve disease and coronary heart disease – the number one killer in Europe.  The COVID-19 pandemic has radically changed the way we […]

By Jean-Luc Lemercier Corporate Vice President Edwards Lifesciences, EMEA, Canada and Latin America & Chair of the Cardiovascular Sector Group of MedTech Europe

shutterstock_578337865
Ethics

Posted on 25.03.2021

New training video boosts global compliance – and public confidence

Bringing innovative medical technology to patients around the world is a priority for the medtech industry. This task often relies on a wide network of third-party intermediaries and distributors. While third parties provide valuable local knowledge, logistics and skills, it is important to appreciate that everyone working on behalf of medtech companies is bound by […]

By Aline Lautenberg General Counsel and Director General Legal & Compliance, MedTech Europe

shutterstock_1920759539
COVID-19

Posted on 25.02.2021

The impact of the pandemic on people living with rare diseases

Almost 12 months after the WHO declared a global COVID-19 pandemic, people with rare diseases can reflect on a turbulent year – even if there are some positive lessons to be learned in how services are delivered. While the pandemic continues, most reflections on the crisis come to a common conclusion: everyone suffered, but not […]

By Sandra Courbier Social Research Director - Rare Barometer Programme Lead

shutterstock_1198926103
COVID-19

Posted on 26.11.2020

In vitro diagnostics at risk: Covid-19 delays progresses towards the new European regulations

In order to keep them available to the health care system and to patients, more than 85% of IVDs will need to be updated in view of the new in vitro Diagnostic Regulation (IVDR) which is at risk due to the ongoing COVID-19 pandemic. The remaining IVDR transition time is not sustainable and requires attention […]

By Natale Bova Chair of the Regulatory IVD Forum of Confindustria Dispositivi Medici

shutterstock_1357664711
COVID-19

Posted on 26.10.2020

COPD & COVID-19: Pandemic must prompt shift to connected care

For people living with chronic obstructive pulmonary disease (COPD), a long-term lung illness, COVID-19 is having a major impact. The pandemic has disrupted traditional models of care and put vulnerable patients at risk. Keeping patients out of hospital – by reducing scheduled visits and avoiding emergency admissions – has become the top priority.  A silver […]

By Odile Bigaignon Vice President, EMEA Marketing at ResMed

shutterstock_1323264992
COVID-19

Posted on 29.09.2020

Your heart has never been more important

The unprecedented COVID-19 has fundamentally shifted society’s and government’s attention and prioritisation of healthcare. Never has health topped our agenda as much as today – as an individual trying to stay healthy, as healthcare professional and facility trying to deliver a high quality of care, as industry trying to deliver the best innovations to improve […]

By Jean-Luc Lemercier Corporate Vice President Edwards Lifesciences, EMEA, Canada and Latin America & Chair of the Cardiovascular Sector Group of MedTech Europe